Yongkui Yu
Henan Cancer Hospital(CN)
Publications by Year
Research Areas
Esophageal Cancer Research and Treatment, Esophageal and GI Pathology, Lung Cancer Diagnosis and Treatment, Gastric Cancer Management and Outcomes, Cancer-related molecular mechanisms research
Most-Cited Works
- → Relationship between expression of PD-L1 and PD-L2 on esophageal squamous cell carcinoma and the antitumor effects of CD8+ T cells(2015)81 cited
- → Sarcopenia and Short-Term Outcomes After Esophagectomy: A Meta-analysis(2020)75 cited
- → Early oral feeding following thoracolaparoscopic oesophagectomy for oesophageal cancer(2014)66 cited
- → Neoadjuvant chemotherapy combined with immunotherapy versus neoadjuvant chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma(2024)51 cited
- → Pathologic responses and surgical outcomes after neoadjuvant immunochemotherapy versus neoadjuvant chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma(2022)41 cited
- → A phase III study on neoadjuvant chemotherapy versus neoadjuvant toripalimab plus chemotherapy for locally advanced esophageal squamous cell carcinoma: Henan Cancer Hospital Thoracic Oncology Group 1909 (HCHTOG1909)(2021)39 cited
- → MicroRNA-490 regulates lung cancer metastasis by targeting poly r(C)-binding protein 1(2016)39 cited
- → MiR-27b suppresses epithelial–mesenchymal transition and chemoresistance in lung cancer by targeting Snail1(2019)38 cited
- → Highlighting sarcopenia management for promoting surgical outcomes in esophageal cancers: Evidence from a prospective cohort study(2020)33 cited
- → Perioperative toripalimab plus neoadjuvant chemotherapy might improve outcomes in resectable esophageal cancer: an interim analysis of a phase III randomized clinical trial(2024)30 cited